In summary, in this study, we identified LAPTM5 as an unreported suppressor of NASH that could negatively regulate the p38/c-JNK pathway by promoting CDC42 lysosome degradation in hepatocytes. Here, MAPK8 is linked to metabolic dysfunction-associated steatohepatitis.